Clinical Trial Update: Apply tACS to Alleviate Anxiety Symptoms [Phase 2]

View source ↗

Summary

Phase 2 clinical trial update investigating transcranial alternating current stimulation (tACS) to alleviate anxiety symptoms.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Anxiety Disorders

Snippet

Sponsor: NeuroCognitive and Behavioral Institute Clinical Research Foundation | Conditions: Anxiety Disorders | Phase 2 | Status: UNKNOWN